NCT03333824 2019-03-25Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced CancerAstraZenecaPhase 1 Completed33 enrolled
NCT00045708 2017-10-18A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade GliomasNational Cancer Institute (NCI)Phase 1/2 Completed57 enrolled 18 charts